Real World Health Care recently sat down with Dr. Razelle Kurzrock, Director, Center for Personalized Cancer Therapy & Clinical Trials Office, University of California San Diego Moores Cancer Center, to discuss the present state and future direction of genomics and immunotherapy. Real World Health Care: Why was the Center for…more.
Editor’s Note: This week, we sit down with Keith Stewart, director of the Mayo Clinic Center for Individualized Medicine. Real World Health Care: Why was the Center for Individualized Medicine formed at the Mayo Clinic? What were its initial goals and how have those goals changed? Keith Stewart: The Center…more.
Editor’s Note: Based on an article originally published in Biotech Primer Weekly. Hearing your doctor utter the words HER2-positive, HR-positive, triple-negative or BRCA mutation can be devastating — even for the most resilient person. Simply put, all are linked to breast cancer. Breast cancer is complex, and a diagnosis can…more.
Editor’s Note: In August, the Tufts Center for the Study of Drug Development (CSDD) hosted a roundtable of R&D leaders focused on development of companion diagnostics that can show their use in conjunction with personalized therapeutics that will lead to positive health outcomes. We spoke with Joshua P. Cohen, Ph.D.,…more.
Personalized medicine – also referred to as precision or stratified medicine – is already changing the way we diagnose and treat disease. As our ability to obtain and analyze large amounts of genetic data increases, so too will the range and power of these personalized tools. The idea of personalized…more.
For more than two years, the staff of and contributors to www.RealWorldHealthCare.org (RWHC) have been proud to share stories about proven healthcare solutions that lower costs, improve access to care, and lead to better patient outcomes. Starting this Fall, RWHC will embark on a new mission. Each quarter, we will…more.
